Screener
Relmada Therapeutics, Inc. RLMD Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055059
| Line item | As of / March 31, | As of |
|---|---|---|
| Stockholders’ Equity: | ||
| Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding | - | - |
| Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding | - | - |
| Common stock, $0.001 par value, 150,000,000 shares authorized, 104,890,223 and 73,333,622 shares issued and outstanding, respectively | 104,890 | 73,333 |
| Additional paid-in capital | 935,946,841 | 784,705,878 |
| Accumulated deficit | (717,319,154) | (698,267,198) |
| Total stockholders’ equity | 218,732,577 | 86,512,013 |
| Total liabilities and stockholders’ equity | $235,362,794 | $94,003,471 |
Item 1. Unaudited Condensed Consolidated Financial Statements
FAQ
- What is Relmada Therapeutics, Inc.'s total liabilities & equity?
- Relmada Therapeutics, Inc. (RLMD) reported total liabilities & equity of $235.36M in Q1 2026.
- How has Relmada Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Relmada Therapeutics, Inc.'s total liabilities & equity increased by 750.3% year-over-year, from $27.68M to $235.36M.
- What is the long-term trend for Relmada Therapeutics, Inc.'s total liabilities & equity?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s total liabilities & equity has grown at a -4.5% compound annual growth rate (CAGR), from $118.19M to $94M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about Relmada Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude